Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma

Table 1 Characteristic features of non-metastatic hepatocellular carcinoma patients and healthy controls

	Average ± SD
HCC and cirrhotic patient parameters
Mean age	49 ± 13.5
Sex: Male/female	22/1
Ethanol abuse	None
AST (U/L)	100.5 ± 65.8
ALT (U/L)	85.6 ± 95.6
Alkaline phosphatase (U/L)	110.2 ± 60.7
Serum albumin (g/dL)	4.6 ± 1.5
Serum AFP (ng/mL)	155.7 ± 22.3
HCV Ab	100% (23/23 HCC patients)
HBV Ab	17.3% (4/23 HCC patients)
Healthy control (liver donor) parameters
Mean age	31 ± 10.5
Sex: Male/female	7/3
Ethanol abuse	None
HCV Ab	None
HBV Ab	None

HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; AFP: Alpha fetal protein; HBV: Hepatitis B virus; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; SD: Standard deviation.